Abstract
When the brains of Wistar rats were extracted 1 1/4 hours after single intraperitoneal injections of radio-active imipramine some desmethylimipramine (DMI) was always found, together with comparable amounts of iminodibenzyl (IdB) and 2 hydroxyimipramine. The total radioactivity recovered from brain, (usually less than 0.2 % of dose) did not rise on repeated daily injection but then proportions of DMI and IdB tended to be higher.
Brain slices incubated for 2 hours at 37° C with radioactive imipramine produced DMI, IdB, and some didesmethylimipramine, but no hydroxylated metabolites. Liver slices produced more DMI, less IdB, a fair amount of 10-hydroxy DMI and comparable 2-hydroxyimipramine. Heart, kidney, lung and gut slices were also active in varying degrees.
These findings are consistent with at least two different metabolic hypotheses of the way imipramine exerts its antidepressant action in man.
Similar content being viewed by others
Abbreviations
- I:
-
imipramine
- DMI:
-
desmethylimipramine
- DDMI:
-
dides methylimipramine
- IdB:
-
iminodibenzyl
- 2 OH-I, 2 OH-IdB:
-
two-hydroxy-imipramine etc.
- 10 OH-DMI:
-
ten-hydroxy-desmethylimipramine
References
Adank, K., Hammerschmidt, W.: Dünnschichtchromatographische Untersuchung von Imipramin. Chimia 18, 361–363 (1964).
Bickel, M. H., Baggiolini, M.: The metabolism of imipramine and its metabolites by rat liver microsomes. Biochem. Pharmacol. 15, 1155–1169 (1966).
—, Brochon, R., Friolet, B., Herrmann, B., Stofer, A. R.: Clinical and biochemical results of a fatal case of desipramine intoxication. Psychopharmacologia (Berl.) 10, 431–436 (1967).
—, Weder, H. J.: The total fate of a drug: kinetics of distribution, excretion, and formation of 14 metabolites in rats treated with imipramine. Arch. int. Pharmacodyn. 173, 433–463 (1968).
— —: Buccal absorption and other properties of pharmacokinetic importance of imipramine and its metabolites. J. Pharm. Pharmacol. 21, 160–168 (1969).
Cassano, G. B., Hansson, E.: Autoradiographic distribution studies in mice with C14-imipramine. Int. J. Neuropsychiat. 2, 269–278 (1966).
—, Sjöstrand, S. E., Hansson, E.: Distribution and fate of C14 amitriptyline in mice and rats. Psychopharmacologia (Berl.) 8, 1–11 (1965).
Christiansen, J., Gram, L. F., Kofod, B., Rafaelsen, O. J.: Imipramine metabolism in man. A study of urinary metabolites after administration of radioactive imipramine. Psychopharmacologia (Berl.) 11, 255–264 (1967).
Collier, H. O. J.: Humoral transmitters, Supersetsitivity, Receptors and Dependence. In: Scientific basis of drug dependence (ed. H. Steinberg). London 1969.
Crammer, J. L., Scott, B., Rolfe, B.: Metabolism of 14C-imipramine. II. Urinary metabolites in man. Psychopharmacologia (Berl.) 15, 207–225 (1969).
— —, Woods, H., Rolfe, B.: Metabolism of 14C-imipramine. I. Excretion in the rat and in man. Psychopharmacologia (Berl.) 12, 263–277 (1968).
Curzon, G.: Tryptophan pyrrolase—a biochemical factor in depressive illness? Brit. J. Psychiat. 115, 1367–1374 (1969).
Dingell, J. V., Sulser, F., Gillette, J. R.: Species differences in the metabolism of imipramine and desmethylimipramine. J. Pharmacol. exp. Ther. 143, 14–22 (1964).
Edwards, G.: Comparison of the effect of imipramine and desipramine on some symptoms of depressive illness. Brit. J. Psychiat. 3, 889–897 (1965).
Gillette, J. R., Dingell, J. V., Sulser, F., Kuntzman, R., Brodie, B. B.: Isolation from rat brain of a metabolic product, desmethylimipramine, that mediates the antidepressant activity of imipramine. Experientia (Basel) 17, 417–418 (1961).
Lewis, S. A., Oswald, I.: Overdose of tricyclic antidepressants and deductions concerning their cerebral action. Brit. J. Psychiat. 115, 1403–1410 (1969).
Michaelis, V., Stille, G.: Demethylation of imipramine and antitetrabenazine effect in the catalepsy and ptosis test. Life Sci. 7, 99–106 (1968).
Mulé, S. J.: The relationship of the disposition and metabolism of morphine in the CNS to tolerance. In: Scientific basis of drug dependence (ed. H. Steinberg). London: Churchill 1969.
Pscheidt, G. R.: Demethylation of imipramine in male and female rats. Biochem. Pharmacol. 2, 501–502 (1962).
Schneider, G., Schneider, G.: Über die Aufnahme des Psychopharmakons Imipramin in das Rattenhirn und seinen Metabolismus bei einmaliger und bei chronischer Gabe des Medikamentes. Psychopharmacologia (Berl.) 14, 74–82 (1969).
— —, Bickel, M. H.: Über das Auftreten von Desmethylimipramin im Gehirn der Ratte nach Gabe von Imipramin in Abhängigkeit von der Injektionsart. Psychopharmacologia (Berl.) 16, 156–160 (1969).
Watt, D. C., Crammer, J. L., Elkes, A.: The relation of side effects to therapeutic outcome of imipramine in depressive illness. In: The present status of psychotropic drugs, pp. 553–555. Excerpta Medica I.C.S. 180 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crammer, J.L., Rolfe, B. Metabolism of 14C-imipramine. Psychopharmacologia 18, 26–37 (1970). https://doi.org/10.1007/BF00402381
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00402381